Novartis Aktie
132,66
EUR
-0,64
EUR
-0,48
%
132,82
EUR
-0,98
EUR
-0,73
%
Werbung
Novartis Aktie Analyse
| 28.01.16 | Novartis Halten | Independent Research GmbH | |
| 28.01.16 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 28.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.01.16 | Novartis Underweight | Barclays Capital | |
| 25.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.01.16 | Novartis buy | UBS AG | |
| 19.01.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.01.16 | Novartis Underweight | Barclays Capital | |
|
Werbung
|
|||
| 14.01.16 | Novartis buy | Jefferies & Company Inc. | |
| 13.01.16 | Novartis Halten | Independent Research GmbH | |
| 11.01.16 | Novartis kaufen | UBS AG | |
| 08.01.16 | Novartis Hold | Deutsche Bank AG | |
| 07.01.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 07.12.15 | Novartis buy | Jefferies & Company Inc. | |
| 02.12.15 | Novartis buy | Citigroup Corp. | |
| 02.12.15 | Novartis Equal-Weight | Morgan Stanley | |
| 30.11.15 | Novartis Hold | Deutsche Bank AG | |
| 25.11.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 11.11.15 | Novartis neutral | Morgan Stanley | |
| 05.11.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.11.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.10.15 | Novartis Halten | Independent Research GmbH | |
| 28.10.15 | Novartis Outperform | Bernstein Research | |
| 28.10.15 | Novartis buy | Kepler Cheuvreux | |
| 28.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis Hold | Deutsche Bank AG | |
| 28.10.15 | Novartis Equal weight | Barclays Capital | |
| 28.10.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 27.10.15 | Novartis Hold | S&P Capital IQ | |
| 26.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.10.15 | Novartis Outperform | BNP PARIBAS | |
| 21.10.15 | Novartis Outperform | Bernstein Research | |
| 21.10.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 16.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 12.10.15 | Novartis buy | Jefferies & Company Inc. | |
| 25.09.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.09.15 | Novartis buy | Citigroup Corp. | |
| 16.09.15 | Novartis buy | HSBC | |
| 10.09.15 | Novartis buy | Jefferies & Company Inc. | |
| 03.09.15 | Novartis Halten | Independent Research GmbH | |
| 01.09.15 | Novartis buy | UBS AG | |
| 24.08.15 | Novartis buy | UBS AG | |
| 07.08.15 | Novartis buy | Jefferies & Company Inc. | |
| 27.07.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 27.07.15 | Novartis buy | UBS AG | |
| 24.07.15 | Novartis buy | Kepler Cheuvreux | |
| 23.07.15 | Novartis Outperform | BNP PARIBAS | |
| 22.07.15 | Novartis Equal weight | Barclays Capital | |
| 22.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
Werbung
Werbung